Plexus Biomed pulls in $2M for hemorrhoid relief
Plexus Biomedical, an Oakland, Tenn., device maker, raised $2 million in a first round of funding, VentureWire reports (subscription required). The investors were undisclosed investment funds.
Plexus is developing a device it hasn’t said much about, although a government Web site revealed that Plexus is conducting a clinical trial of a device intended to reduce hemorrhoids during vaginal delivery.
Next Story: Swarmcast streams live events in HD
Previous Story: iCeutica raises $1.1M for reformulated drugs
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
